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Abstract
Background: Outbreaks of poliomyelitis in African countries that were previously free of wild-type poliovirus cost the Global
Polio Eradication Initiative US$850 million during 2003–2009, and have limited the ability of the program to focus on
endemic countries. A quantitative understanding of the factors that predict the distribution and timing of outbreaks will
enable their prevention and facilitate the completion of global eradication.
Methods and Findings: Children with poliomyelitis in Africa from 1 January 2003 to 31 December 2010 were identified
through routine surveillance of cases of acute flaccid paralysis, and separate outbreaks associated with importation of wild-
type poliovirus were defined using the genetic relatedness of these viruses in the VP1/2A region. Potential explanatory
variables were examined for their association with the number, size, and duration of poliomyelitis outbreaks in 6-mo periods
using multivariable regression analysis. The predictive ability of 6-mo-ahead forecasts of poliomyelitis outbreaks in each
country based on the regression model was assessed. A total of 142 genetically distinct outbreaks of poliomyelitis were
recorded in 25 African countries, resulting in 1–228 cases (median of two cases). The estimated number of people arriving
from infected countries and ,5-y childhood mortality were independently associated with the number of outbreaks.
Immunisation coverage based on the reported vaccination history of children with non-polio acute flaccid paralysis was
associated with the duration and size of each outbreak, as well as the number of outbreaks. Six-month-ahead forecasts of
the number of outbreaks in a country or region changed over time and had a predictive ability of 82%.
Conclusions: Outbreaks of poliomyelitis resulted primarily from continued transmission in Nigeria and the poor
immunisation status of populations in neighbouring countries. From 1 January 2010 to 30 June 2011, reduced transmission
in Nigeria and increased incidence in reinfected countries in west and central Africa have changed the geographical risk of
polio outbreaks, and will require careful immunisation planning to limit onward spread.
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Introduction
The success of the oral poliovirus vaccine (OPV) in eliminating
polio in the Americas led to a commitment by the governments of
the world to eradicate polio at the World Health Assembly in
1988. Since that time, widespread use of OPV has reduced the
number of children paralysed by polio from an estimated 350,000
in 1988 to just 1,606 in 2009 [1]. Early estimates of incidence in
the African continent are affected by substantial under-reporting;
however, 4,546 cases were reported in Africa in 1988, and by 2009
this was reduced to 693 cases [2]. This decrease in reported cases
has been accompanied by a marked reduction in the geographic
extent of endemic areas, such that by 2006 just four countries had
yet to interrupt indigenous wild-type poliovirus transmission
worldwide, and in Africa only Nigeria was endemic for polio.
Transmission has been persistent in those countries, and onward
spread to previously polio-free areas has presented significant
challenges to the Global Polio Eradication Initiative (GPEI).
Continued circulation of wild polioviruses in Nigeria and India
led to reinfection of 19 African countries in 2009 alone [1], and
cost the GPEI nearly US$150 million that year. Four of the
reinfected countries (Angola, Chad, the Democratic Republic of
the Congo [DRC], and Sudan) were considered to have re-
established poliovirus transmission, requiring eradication efforts
and resources proportionate to those in the endemic countries [3].
Efforts to control poliovirus in these reinfected countries have
continued in 2010 with some success, notably in Sudan [4].
Despite the reported successes, importation of poliovirus to polio-
free countries has continued. For example, the importation of
poliovirus to the Congo in 2010 caused the first outbreak of
poliomyelitis in that country in 10 y, resulting in approximately
554 cases [5]. Development of the GPEI Strategic Plan 2010–2012
builds upon lessons learnt during previous experiences, and
includes novel approaches to interrupting poliovirus transmission
and preventing outbreaks [6]. The analysis presented here is part
of the framework within the Strategic Plan to use statistical and
mathematical models to aid decision making.
The risk of an importation of wild-type poliovirus into a
country (where an importation is a case of poliomyelitis for which
the associated poliovirus in a stool sample has a genetic sequence
distinct from cases already indentified in that country) is likely to
be influenced by exposure to poliovirus circulating in other
countries and the immunity profile of the local population [7].
Environmental and demographic characteristics related to
crowding, population movement, and sanitation are also likely
to play a role. The relative importance of different population
characteristics, and the effect of routine immunisation and
supplementary immunisation activities (SIAs) on the number
and size of outbreaks experienced by a country, have not been
formally assessed or quantified. Here we use detailed surveillance
data from 56 countries in Africa to identify the most important
risk factors for an outbreak, and to identify those variables
associated with a reduced number of outbreaks and rapid
interruption of the imported wild virus. Furthermore, we examine
the predictive ability of a statistical model based on these
variables to identify countries and regions at risk of an outbreak
6 mo ahead of time.
Methods
Description of the Data
Outbreaks of poliomyelitis that occurred on the African
continent between 1 January 2003 and 31 December 2010 were
identified through routine surveillance of cases of acute flaccid
paralysis (AFP). All countries reported cases of AFP through a
network of health care workers to achieve a minimum surveillance
standard of one non-polio AFP case per 100,000 children under
15 y of age. A case of poliomyelitis was confirmed when wild-type
poliovirus was isolated from at least one of two stool samples
collected from each child with AFP. Outbreaks were defined on
the basis of their genetic identity and their location. The serotype,
genotype, and cluster were investigated by the US Centers for
Disease Control and Prevention and the World Health Organi-
zation (WHO) to define epidemiologically linked cases, where the
presence of different capsid proteins defined the serotype [8],
.85% nucleotide similarity of the VP1/2A interval defined the
genotype [9], and independent transmission pathways determined
by evolutionary divergence defined the cluster [10,11]. An
outbreak was defined as one or more cases of poliomyelitis within
a country that had never previously reported other cases
genetically linked to that cluster. Even a single child with AFP
and wild-type poliovirus in stool samples was considered an
outbreak if associated with a unique genetic cluster of poliovirus,
because each reported case of paralysis is likely to be associated
with several hundred or more asymptomatic or unreported
infections [12]. Only outbreaks of wild-type virus were considered;
vaccine-derived poliovirus outbreaks were excluded from the
analysis.
Spread of a virus cluster across a country border resulted in the
recording of the associated cases as a new outbreak in the newly
affected country. The DRC, Ethiopia, and Sudan were split into
regions because of their size and because immunisation activities
were often carried out in discrete regions smaller than the size of
the country. Additionally, the reported number of OPV doses
varied considerably between these regions, as a result of the
different vaccination schedules, coverage of the population
through routine vaccination services, and socio-economic factors
(see Text S1). In these countries, spread of a cluster from one
region to the next was regarded as a new outbreak.
Explanatory variables were generated at a country level or a
regional level (DRC, Ethiopia, and Sudan) and grouped into 6-mo
intervals to account for changes over time. Explanatory variables
that were tested in the model included those related to population
immunity and underlying characteristics such as population
density, childhood mortality, and indices of poverty that may
influence outbreak susceptibility. Measures of population immu-
nity included country-specific estimates of routine coverage from
WHO/United Nations Children’s Fund (the proportion of
children who have received three or more doses of trivalent
OPV by their second birthday through routine immunisation), and
the proportion of children aged 0–4 y old who received three or
more doses of OPV of any type, obtained from non-polio AFP
records. The reported vaccination status of children under 5 y of
age who had AFP and from whom two adequate stool samples
were collected but without any poliovirus isolated (referred to as
non-polio AFP cases) was assumed to reflect the vaccination status
of the rest of the community, based on previous research [13,14].
A variable termed ‘‘poliovirus exposure’’ (l) was used to
describe exposure in a given country to wild-type poliovirus due
to movement of people from other countries with circulating
poliovirus. Four data sources approximating population move-
ment between African countries and from the remaining endemic
countries (Afghanistan, India, Nigeria, and Pakistan) were
examined for their association with poliomyelitis outbreaks.
These sources describe the number of passengers on flights in
2008 [15], permanent migrants in 2001 [16], tourists in 2004
[17], and the population size of each pair of countries scaled by
the physical distances between their capital cities (also known as a
Prevention of Poliomyelitis Outbreaks in Africa
PLoS Medicine | www.plosmedicine.org 2 October 2011 | Volume 8 | Issue 10 | e1001109
gravity model [18]; see Text S1). Poliovirus exposure in a given 6-
mo period t experienced by country j from country i was
calculated as
lj,t~
Xn
i~1
mi,jxi,t{1, ð1Þ
where mi,j is the reported number of individuals in each dataset
who moved from i to j (or other approximation), xi,t{1 is the
number of poliomyelitis cases reported in country i during the
preceding 6-mo period, and n is the number of countries. In other
words, the incidence in country i at t21 was multiplied by the
reported number of movements from i to j, and this value was
summed for all countries in Africa to obtain the total poliovirus
exposure in country j. In addition, the contribution of specific
regions or countries to poliovirus exposure was examined by
calculating this measure separately for exposure from Nigeria,
from other countries in Africa, and from Afghanistan, India, and
Pakistan (the remaining endemic countries outside of Africa).
Poliovirus exposure from the previous 7–12 and 13–18 mo was
also examined to explore time-varying effects. Six-month
intervals were chosen for this analysis to maximise temporal
resolution but at the same time ensure that estimates of vaccine
coverage were based on a sufficient number of children with AFP.
Statistical Analysis
Regression models were used to identify factors associated with
the number of wild poliovirus outbreaks reported by a country or
region for every 6 mo of the study period, the duration of these
outbreaks, and their size. A Poisson mixed effects regression model
was used to identify factors associated with the number of
outbreaks from 1 July 2004 to 31 December 2010. A mixed effects
model structure was used to account for multiple observations per
country. A Poisson log-normal mixed effects model, which
accounts for overdispersion of the number of outbreaks, was also
tested, and the predictive ability of both models compared [19].
Outbreaks that began prior to 1 July 2004 were excluded from the
analysis as there were no data on population immunity or
poliovirus exposure prior to 18 mo before this time period
(January 2003 was the first available time point for the data).
Explanatory variables significant (p,0.2) at a univariable level
were incrementally added to the multivariable model if the
Akaike’s information criterion (AIC) reduced significantly in value,
known as a stepwise addition approach [19]. Interactions were
tested between variables in the multivariable model, and all
variables were tested for their inclusion and interactions with
variables in the final model. 95% confidence intervals (CIs) for the
model fit were calculated from the standard error (SE) of the fixed
effects. Models were implemented in the software STATA (version
11.0).
The regression analysis of the number of outbreaks included
only variables from previous time periods, and so it was possible to
forecast the number of outbreaks expected in a country 6 mo
ahead of time. The predictive accuracy of these forecasts was
estimated using prospective sampling, where the longitudinal data
used to estimate regression model parameters were truncated and
forecasts of the next 6 mo compared with observed data [20]. Six-
month-ahead predictions were made for 1 July–31 December
2007 onwards. For each model prediction, the limits of the
prediction interval were obtained from the 2.5 and 97.5 percentiles
of the negative binomial distribution, with mean equal to the
model prediction and variance equal to the sum of the variance of
the model prediction and the variance around the expected value
associated with a Poisson distribution [21]. Receiver operator
characteristic analysis was used to assess the accuracy of the
predictions, where the area under the curve (AUC) was estimated
using a binormal parametric model [22]. The estimated value of
the AUC is equivalent to the probability that a randomly drawn
country where an outbreak was detected had a greater predictive
value than a randomly drawn country where no outbreak was
detected. The AUC value should at least be greater than 0.50
(which would indicate that the model is no better than random),
and values above 0.80 indicate a good predictive ability [23,24].
The Poisson model and the Poisson log-normal model were tested
for their predictive ability. By way of comparison, the number of
outbreaks per country in the previous 3 y was used as a measure of
historical propensity for outbreaks and used to predict whether an
outbreak would occur in the current 6 mo (other time periods
were also explored; see Text S1). To predict likely outbreaks in the
period 1 January–30 June 2011, data on outbreaks from the period
1 July 2004 to 31 December 2010 were used in the regression
model to estimate coefficients, and these coefficients were
combined with predictors as measured in the preceding 6 mo.
Factors associated with the duration of outbreaks were modelled
using a Cox proportional-hazards model with censoring to account
for ongoing outbreaks [25]. The duration of an outbreak was
defined as the time (in days) from the first to the last case of an
outbreak. Outbreaks were declared over when there were no
epidemiologically linked cases in the country or region for at least
6 mo after the last case; otherwise, outbreaks were assumed to be
ongoing. Factors affecting the size of an outbreak were investigated
using a censored negative binomial generalised linear model, as
the variance was larger than the mean size of outbreaks [26]. For
analyses of outbreak duration and size, those that began between 1
July 2003 and 31 June 2010 were included in the analysis.
Results
Distribution of the Size and Geographic Extent of
Poliomyelitis Outbreaks in Africa
Between 1 July 2003 and 31 December 2010 there were 25
countries in Africa that reported an outbreak of polio, corre-
sponding to 137 outbreaks. When these outbreaks were further
divided into the regions within Ethiopia, Sudan, and DRC, this
corresponded to 142 outbreaks; the rest of the analysis refers to
these data. The median size of outbreaks was two cases (range 1–
228; Figure 1A), and the median duration of outbreaks was 39 d
when not accounting for censoring. Four outbreaks with cases
reported after 1 July 2010 were classified as ongoing outbreaks that
were censored. Eighty-one outbreaks (57%) consisted of more than
one case of poliomyelitis, and the median duration of these
outbreaks was 158 d. After correcting for censoring, the Kaplan-
Meier estimates of the median duration of the 81 multiple-case
outbreaks was 163 d (Figure 1B).
The average number of outbreaks experienced by each country
or region declined with physical distance from Nigeria (Figure 2A).
Cameroon, Chad, and Niger, all bordering Nigeria, reported nine
or more outbreaks each during the study period, and Niger
reported 33 outbreaks, of which 21 were single cases. Benin, also
bordering Nigeria, reported seven outbreaks during the study
period. Further away from Nigeria, Mali, Burkina Faso, and the
Central African Republic reported five or more outbreaks each.
Eight countries—Botswana, Burundi, the Congo, Eritrea, Maur-
itania, Namibia, Sierra Leone, and Somalia—reported only one
outbreak during the study period (further details are given in Text
S1). South Sudan, south DRC, northeast Ethiopia, and southeast
Ethiopia reported one outbreak each during the study period.
Prevention of Poliomyelitis Outbreaks in Africa
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Factors Associated with the Risk of Outbreaks
Fifteen explanatory variables were associated (p,0.2) with the
number of outbreaks in the univariable analysis, and were used to
develop the multivariable model (Table 1). The final Poisson
mixed effects regression model retained five explanatory variables
(Table 2). These included the measure of exposure to wild-type
polioviruses based on the distribution of children with poliomyelitis
in the preceding 6 mo and migration from affected countries.
Poliovirus exposure measured by the number of permanent
migrants moving between countries was found to provide a better
fit to the data than exposure terms based on the movement of
tourists, flight data, or physical distance. If exposure was higher in
the previous 6 mo than 18 mo ago, there was an additional
increase in risk. Countries physically bordering Nigeria (Benin,
Chad, Niger, and Cameroon), with poor immunisation coverage
(based on AFP data) and high child mortality also had an increased
risk of an outbreak.
Niger, Chad, and Cameroon reported more than nine
outbreaks, and this was replicated in the model, although Mali
had more outbreaks than expected (9 compared with 5.31;
Figure 2B). In west Africa, there were generally slightly more
reported outbreaks than expected from the model. For example,
the Ivory Coast reported two outbreaks and the model expectation
was 1.32 outbreaks. For Eritrea, Gabon, Equatorial Guinea, and
countries south of DRC, which did not report outbreaks during
the study, the model expectation was that each would have had at
least one outbreak. Countries in north Africa (Algeria, Egypt,
Libya, Morocco, and Tunisia) reported no outbreaks, which was
similar to what was expected in the model. The temporal fit of the
number of outbreaks showed a large number of outbreaks in the
second halves of 2004 and 2008, and a reduction in outbreaks
during 2007 and 2010 (Figure 2C). However, the large number of
outbreaks observed from mid-2008 to 2009 and the ten outbreaks
observed in 2010 were not replicated in the model. The 95% CI of
the model fit included the reported number of outbreaks, but the
CIs were wide, particularly when a large number of outbreaks was
observed.
When routine vaccination coverage in the preceding 6 mo was
included in the regression model instead of vaccine coverage based
on the reports for non-polio AFP cases, the fit of the model
worsened (AIC of the model was 553.82 compared to 548.06; see
Text S1). However, routine coverage was correlated with the
proportion of non-polio AFP cases reporting at least three doses of
OPV (correlation coefficient 0.54, p,0.001; see Text S1).
Forecasting the Number of Outbreaks in Africa
The AUC of the Poisson regression model was 0.82 (SE= 0.03),
indicating a good predictive ability for the number of future
outbreaks. In other words, 82% of the time for a randomly selected
country (or region) and period where an outbreak was observed,
the predicted number of outbreaks was greater than any other
randomly selected country (or region) and period where no
outbreak was observed. The Poisson log-normal mixed effects
regression model had a reduced predictive ability of 0.77
(SE= 0.05), despite an improved fit to the data (AIC of the
Poisson log-normal model was 528.39 compared to 548.06).
Therefore, the rest of the analyses are based on results from the
Poisson regression model. The model that used the number of
outbreaks in the previous 3 y as a predictor for outbreaks in the
current 6 mo had a predictive ability of 0.76 (SE= 0.04). The
model of historical propensity can predict outbreaks only in
countries that have previously reported an outbreak, whereas the
Poisson regression model predicts the risk of an outbreak based
upon values of the parameters and coefficients. Inspecting the
predictive map for 2010 shows that Niger, Chad, and Cameroon
were predicted to have the highest chance of an outbreak, but only
Niger and Chad reported outbreaks within the 6-mo period
(Figure 3A). Mali and Senegal reported two or more outbreaks but
were predicted to have fewer outbreaks than either Niger or Chad.
In the second half of 2010 the Congo and Uganda were predicted
to have an increased risk when compared to the previous time
period, and an outbreak was reported in both countries during this
time. The predicted increase in risk in countries south of DRC
(Angola, Zambia, and Rwanda, for example) in 2010 has not been
associated with any reported outbreaks to date (although Angola
has persistent transmission from a previous outbreak). The
temporal trends illustrate that the model was able to predict the
decrease in outbreaks in the first half of 2007, both halves of 2009,
and the second half of 2010 when compared to previous time
periods, and predicted the increase in outbreaks in the second
halves of 2007 and 2008 (Figure 3B). For all time periods, the 95%
prediction intervals include the observed number of outbreaks,
and, with the exception of 2011, the prediction intervals decrease
in size with the addition of more data.
Based on data prior to 1 January 2011, the predicted number of
outbreaks in Africa from 1 January to 31 June 2011 was 9.10 (95%
prediction interval = 2–19 outbreaks). The nine countries with the
highest predicted risk were, starting with the highest, Niger,
Angola, Mali, Central African Republic, the Congo, Uganda,
Figure 1. Distribution of the size and duration of outbreaks in
Africa 2003–2010. (A) Size of outbreaks. (B) Duration of outbreaks.
Where no epidemiologically linked cases have been detected in the last
6 mo the final size is reported. If cases have been recently (1 July–31
December 2010) detected, the size and duration are censored. All
censored outbreaks are denoted by the blue tick marks in the Kaplan-
Meier curve (B).
doi:10.1371/journal.pmed.1001109.g001
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Zambia, Rwanda, and Cameroon. As of 12 July 2011, five
countries had reported outbreaks: Coˆte d’Ivoire, Guinea, Gabon,
Mali, and Niger [27].
Factors Associated with the Duration and Size of an
Outbreak
Of the 137 outbreaks recorded prior to 1 July 2010, 133 (97%)
were fully observed and the remainder were right censored (i.e.,
were regarded as ongoing outbreaks). The hazard ratio of a Cox
proportional-hazards model represents the effect of a unit change
in the explanatory variable on the frequency of the outcome,
which in this case is the last case of an outbreak. Higher
vaccination coverage in the 6 mo prior to an outbreak and sharing
a border with Nigeria were both associated with shorter and
smaller outbreaks (Tables 3 and 4). In addition, an annual AFP
rate greater than two cases per 100,000 children under 15 y of age
was associated with smaller outbreaks (Table 3).
Discussion
In this paper we demonstrate a clear link between vaccination
coverage and population movement from endemic regions and the
risk of outbreaks of poliomyelitis in Africa. Significant temporal
and geographic variation in the number of reported outbreaks is
explained by changes in population immunity and exposure to
wild poliovirus imported by travellers from affected countries.
Notably, a model incorporating population movement propor-
tional to the number of permanent migrants was found to fit the
data better than models based on physical distance, tourism, or
flight data. The identified risk factors are sufficient to describe the
scale and geographic distribution polio outbreaks in Africa 6 mo in
Figure 2. Distribution of the risk of poliomyelitis outbreaks in Africa. (A) The number of poliomyelitis outbreaks reported for each country in
Africa between 1 July 2004 and 31 December 2010. (B) The expected number of poliomyelitis outbreaks for each country in Africa based on the fit of
the Poisson mixed effects model. (C) The temporal fit of the Poisson mixed effects model, where error bars show the 95% CIs, and the reported
number of outbreaks for each 6-mo period.
doi:10.1371/journal.pmed.1001109.g002
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advance with a predictive ability of 82%. Given the resource
constraints frequently faced by the eradication programme,
planning SIAs on the basis of a statistical model that describes
evolving risk is therefore a useful supplement to expert review of
epidemiological and vaccination data. Indeed, the statistical model
presented here has been used to help plan SIAs in Africa that are
described in the GPEI Strategic Plan for 2010–2012 [6].
Furthermore, a 6-mo forecast based on current AFP data can be
a helpful aid to the planning of preventive SIAs despite the time
taken to analyse the data and the 6-wk lead time required to
ensure that sufficient vaccine stocks are available from pharma-
ceutical companies (personal communication, M. Shirely, United
Nations Children’s Fund). As an example, AFP data up to 31
December 2010 were available for analysis on 25 January 2011
and were used to predict likely outbreaks from 1 January–30 June
2011. The results from the predictive risk model were commu-
nicated to WHO immunisation planners on 16 February 2011.
Our analysis highlights how the geographical risk of poliomy-
elitis outbreaks has changed over time, particularly in 2010 and
2011, moving from countries surrounding Nigeria to countries
bordering those with re-established transmission. This predicted
change in risk has been followed by outbreaks in the Congo and
Uganda during the period 1 July–31 December 2010. In order to
prevent future outbreaks, it is vital that poliovirus transmission is
Table 1. Univariate analysis of variables associated with the number of poliomyelitis outbreaks in Africa from 1 January 2004 to 31
December 2010.
Description Data Source Incidence Risk Ratio p-Value
Median 2.5th Percentile CI 97.5th Percentile CI
Estimates of poliomyelitis exposure
Using data on international migrants from all African
countries; 1 unit increase (when logged)
[16]; WHO 1.61 1.36 1.87 ,0.001
Using data on international migrants from Nigeria; 1 unit
increase (when logged)
[16]; WHO 1.36 1.19 1.53 ,0.001
Using data on international migrants from Asia; 1 unit
increase (logged)
[16]; WHO 0.94 0.81 1.02 0.27
Using data on international migrants: exposure 6 mo
ago from all African countries was higher than that
18 mo ago (versus lower)
[16]; WHO 2.67 1.80 3.91 ,0.001
Using data on international tourism from Nigeria only;
1 unit increase (when logged)a
[17]; WHO 1.22 1.10 1.35 ,0.001
Using distance between capital cities from all African
countries; 1 unit increase (logged)
WHO 1.45 1.20 1.71 ,0.001
Using distance between capital cities from Nigeria;
1 unit increase (logged)
WHO 1.43 1.13 1.58 ,0.001
Country borders Nigeria (versus does not) — 13.37 4.82 29.56 ,0.001
Estimates of population immunity
10% increase in the percentage of non-polio AFP
cases reporting three or more doses of OPV
WHO 0.81 0.68 0.91 ,0.001
10% increase in the percentage of children reporting
three doses of the OPV through routine coverage
UN/WHO 0.85 0.72 0.99 0.03
Median number of OPV doses reported in non-polio
AFP cases; 1 unit increase
WHO 0.85 0.71 1.03 0.1
10% increase in the percentage of non-polio AFP
cases reporting no doses of OPV
WHO 1.26 0.98 1.62 0.06
Other factors
10% increase in percentage of the population
aged 0–14 y
[33] 5.62 2.20 14.33 ,0.001
Country reported a ,5-y mortality rate greater than
150 deaths per 1,000 at-risk population (versus lower)
UN 2.88 1.24 6.71 ,0.001
10% increase in the percentage of the population
below the poverty line (country definitions vary)
[33] 1.08 0.87 1.35 0.55
Density of population (people per km2); 1 unit increase [33] 0.99 0.99 1.00 0.07
Population size; 1 unit increase (logged) [33] 1.37 0.86 2.20 0.15
Number of AFP cases reported per country in children
under 5 y; 1 unit increase
WHO 1.00 1.00 1.00 0.81
AFP rate (cases per 100,000 population aged 0–14 y);
1 unit increase
WHO 0.96 0.78 1.19 0.71
n=622 from 56 countries.
aNo tourists were reported from Nigeria for nine countries, all of which are comparatively small in population size. To include these countries in the analysis 0.5 was
added to the number of tourists before multiplying by the incidence in Nigeria and log-transforming the data.
doi:10.1371/journal.pmed.1001109.t001
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Table 2. Final multivariable Poisson mixed effects model describing variables associated with the number of poliomyelitis
outbreaks in Africa from 1 January 2004 to 31 December 2010.
Description of Risk Factor Incidence Risk Ratio p-Value
Standard Deviation
of Random Effect
Median
2.5th
Percentile CI
97.5th
Percentile CI
Poliomyelitis exposure from all African countries; 1 unit
increase (when logged)
1.33 1.15 1.54 ,0.001 N/A
Poliomyelitis exposure in previous 6 mo was higher than
exposure 18 mo ago (versus lower)
1.91 1.27 2.87 0.002 N/A
Country borders Nigeria (versus does not) 5.39 2.69 10.78 ,0.001 N/A
10% increase in the percentage of non-polio AFP cases
reporting three or more doses of OPV
0.85 0.75 0.97 0.013 0.71
Country reported a ,5-y mortality rate greater than
150 deaths per 1,000 at-risk population (versus lower)
2.3 1.3 4.08 0.004 N/A
n=622 from 56 countries; AIC = 548.06.
N/A, not applicable.
doi:10.1371/journal.pmed.1001109.t002
Figure 3. Six-month-ahead predictions and comparison to the observed number of outbreaks. (A) Predictions from 1 January 2010 to 30
June 2011 are illustrated from left to right, along with the observed number of outbreaks for the first and second halves of 2010. (B) The temporal
predictions from 2007 (red lines) and the prediction intervals (dashed red lines) are illustrated. The observed number of outbreaks for each 6-mo
period are overlaid (black lines). The predictive ability of the model was estimated to be 82%. Years (e.g., 2010) indicate the first half of the year (1
January–30 June); years plus 0.5 (e.g., 2010.5) indicate the second half of the year (1 July–31 December).
doi:10.1371/journal.pmed.1001109.g003
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halted in these reinfected countries, as well as in Nigeria.
Predictions in 2011 have overestimated the risk in countries south
of DRC; with additional longitudinal data the apparent reduced
risk may adjust.
Poliovirus exposure estimated from migration and polio
incidence accounted for much of the spatial heterogeneity in the
number of expected outbreaks per country. In addition, countries
bordering Nigeria had a higher number of outbreaks than those
not sharing a border. Much of this increased risk will be due to
additional local population movement that occurs in addition to
that captured by the migration database. We also examined
alternative measures of population movement, including interna-
tional flight and tourism data. However, we found movement that
was assumed to be proportional to the number of permanent
migrants provided the best fit to the data, presumably because
permanent migration is related to broader patterns of cross-border
and international travel that is not captured by these other
measures. Inclusion of a variable describing changes in exposure to
poliovirus over the preceding 18 mo further improved the model
fit, presumably capturing aspects of wild-type poliovirus dynamics
that are not described by other variables. This may include
naturally acquired immunity from the many asymptomatic
infections that occur during an outbreak but are not detected
using AFP surveillance.
The ability of our study to estimate the impact of routine
immunisation and SIAs on population immunity was limited
because estimates of routine coverage are known to be measured
with error [28], and new methods for surveillance of SIA coverage
were only introduced in 2009 [29]. Estimates of trivalent and
monovalent OPV effectiveness against poliomyelitis in Nigeria
have been used to examine the level and trends in immunity
against each poliovirus serotype [13]. Using estimates of immunity
derived in this way was not possible here because of the absence of
accurate estimates of vaccine effectiveness for most countries in
Africa.
An association of ,5-y mortality greater than 150 deaths per
1,000 live births with a higher risk of poliomyelitis outbreaks is
likely to be indicative of poor sanitary conditions, poverty, high
population density, and poor access to health care and nutrition.
These factors contribute both to high childhood mortality and
poliomyelitis susceptibility [30,31]. Many countries in Africa have
reported an improvement in childhood mortality rates [32], and so
susceptibility to outbreaks may be further limited through
investment in health care and living conditions.
A limitation of our study is the use of a statistical model that
may not capture some of the important non-linearities of
poliovirus transmission as eradication is approached. For example,
increasing population immunity above a critical vaccination
threshold results in herd immunity and could eliminate the risk
of polio outbreaks. The log-linear form of the Poisson regression
model does not capture these kinds of thresholds. However, no
such thresholds were apparent in the data at a country level. The
analysis relies on relatively consistent reporting rates for non-polio
AFP, as this appears to provide the best estimate of population
immunity. Unfortunately, not all countries reported a consistently
high AFP rate, which will introduce uncertainties in the analysis.
In addition, estimates of human migration and poliovirus exposure
across Africa were shown to be associated with polio outbreaks,
but there is likely to be much temporal variation in human
movement patterns that was not captured in the available data.
This could explain why the magnitudes of the polio outbreaks in
mid-2004 and mid-2008 were not fully captured by the model, and
why the westward spread of polio from Nigeria in 2008 and 2009
was not completely replicated in the model. Other sources of
movement patterns within Africa are required to fully capture this
important determinant of disease transmission.
Table 3. Final multivariable Cox proportional-hazards survival model describing variables associated with outbreak duration.
Description of Risk Factor Hazard Ratio p-Value
Median 2.5th Percentile CI 97.5th Percentile CI
10% increase in the percentage of non-polio AFP reporting
three or more doses of OPV
1.14 1.03 1.26 0.011
Country borders Nigeria (versus does not) 1.58 1.11 2.24 0.010
n=136 observations; log-likelihood =2532.25.
The hazard ratio represents the effect of a unit change in the explanatory variable on the frequency of the outcome, which in this case is the last case of an outbreak. If
the hazard ratio for a variable is greater than 1.00, an increase in the variable results in an increase of the hazard. In other words, when the value of the variable
increases, an outbreak is expected to be of a shorter duration.
doi:10.1371/journal.pmed.1001109.t003
Table 4. Final multivariable negative binomial model describing variables associated with the number of cases reported during an
outbreak.
Variable Incidence Risk Ratio p-Value
Median 2.5th Percentile CI 97.5th Percentile CI
10% increase in the percentage of non-polio AFP cases reporting
three or more doses of OPV
0.85 0.76 0.96 0.032
Country borders Nigeria (versus does not) 0.41 0.27 0.63 ,0.001
AFP rate is greater than two cases per 100,000 population
aged 0–14 y (versus less than)
0.49 0.30 0.80 ,0.001
n=135; log-likelihood =2385.7.
doi:10.1371/journal.pmed.1001109.t004
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Countries bordering Nigeria experienced more frequent
outbreaks, but in general these were reduced in duration and size
compared with outbreaks in other countries in Africa. This
association could be explained by unmeasured increases in
population immunity following exposure to wild-type poliovirus.
If natural exposure to poliovirus is the cause of the reduced risk,
outbreak size in these countries should be carefully monitored as
the incidence in Nigeria reduces. Serological surveys for antibodies
to poliovirus within populations in Africa would also supplement
current surveillance for AFP and poliovirus in understanding polio
epidemiology.
Although there is always an element of uncertainty and chance
in the distribution of infectious disease outbreaks, this study
highlights that poliomyelitis outbreaks in Africa are largely
governed by the extent of immunity in the population, population
movement, and exposure to infection. Planning SIA campaigns
based on evolving risk may reduce the number of outbreaks by
responding to increased risk prior to an outbreak occurring. As the
incidence of polio in Nigeria has remained very low in 2010 and
2011, there may be a unique opportunity to eliminate polio from
Africa in the near-term through targeted vaccination informed by
appropriate predictive models.
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Editors’ Summary
Background. During the first half of the 20th century, polio
(poliomyelitis) was one of the most feared infectious diseases
in industrialized countries, paralyzing thousands of young
children every year. The virus that causes polio enters the
human body through ingestion of contaminated water or
food, multiplies in the gut, and is shed through the feces
(stool) into the environment, where it spreads rapidly if
sanitation or personal hygiene is poor. Most people infected
with poliovirus have no symptoms, but about one in 200
infected people develop paralytic polio, in which poliovirus
invades and destroys the nerve cells that control the arm and
leg muscles, leading to acute flaccid paralysis (AFP; limb
paralysis). In the worst cases, poliovirus paralyzes the
muscles involved in breathing, which can be fatal unless
patients are helped to breathe with an ‘‘iron lung’’ or
ventilator. There is no cure for paralytic polio, and although
AFP usually lasts less than two weeks, some patients never
regain full use of their limbs.
Why Was This Study Done? From 1955 onwards, routine
polio vaccination rapidly reduced or eliminated wild polio
(polio occurring through natural infection) in developed
countries, but the disease remained common in developing
countries. Consequently, in 1988, the Global Polio
Eradication Initiative was launched. Between 1988 and
2009, routine vaccination and supplementary immunization
activities (additional doses of polio vaccine given to all
young children on national immunization days) reduced the
annual number of children paralyzed by polio from 350,000
to about 1,600 and the number of countries where polio is
endemic (always present) from 125 to four. Unfortunately,
continued circulation of wild polioviruses in Nigeria and India
resulted in reinfection of 19 African countries in 2009 and re-
establishment of polio transmission in four countries. A
better understanding of the factors that affect the
distribution and timing of wild polio outbreaks might help
experts prevent such outbreaks and could facilitate global
polio eradication. Here, the researchers develop a statistical
model of the spread of wild polioviruses in Africa and assess
its ability to predict polio outbreaks in individual African
countries.
What Did the Researchers Do and Find? The researchers
used routine AFP surveillance to identify children who
developed polio in Africa between 2003 and 2010. They
determined whether each case was associated with the
importation of wild poliovirus based on genetic analysis the
polioviruses and then used ‘‘multivariable regression
analysis’’ to identify factors associated with the number,
size, and duration of polio outbreaks. During the study
period, 142 genetically distinct polio outbreaks (involving
one to 228 cases) were recorded in 25 African countries, with
the average number of outbreaks in each country declining
with reduced population movements from each infected
country. The estimated number of people migrating into a
country from an infected country was associated with the
number of outbreaks in that country. Thus, countries with a
high rate of immigration from Nigeria and other countries
where polio is still endemic had more polio outbreaks than
countries with less immigration from these countries. A
country’s mortality rate for children under 5 years of age (an
indicator of sanitary conditions and access to health care)
was also associated with the number of outbreaks, and
immunization coverage was associated with the size,
duration, and number of outbreaks. Finally, in 82% of
instances, for a randomly selected country where an
outbreak was observed, the statistical model predicted six
months ahead of time more outbreaks for that country than
for any randomly selected country where there were no
outbreaks. That is, the model’s predictive ability was 82%.
What Do These Findings Mean? These findings indicate
that outbreaks of polio in Africa over the study period
resulted mainly from continued transmission in Nigeria and
other countries that reported polio cases and from poor
immunization status. They also highlight how the
geographical risk of polio is changing over time in Africa.
Importantly, the risk factors included by the researchers in
their statistical model are sufficient to describe the scale and
geographical distribution of polio outbreaks in Africa six
months in advance with a high predictive ability. Although
the accuracy of the predictions made by the model is limited
by the structure of the model and by the data fed into it, the
information provided by this and other predictive models
should help the Global Polio Eradication Initiative plan its
future immunization and surveillance campaigns and should
facilitate the elimination of polio from Africa.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001109.
N The Global Polio Eradication Initiative provides information
about polio and about global efforts to eradicate the
disease; its website includes links to videos about global
polio elimination efforts
N The World Health Organization provides information about
polio and attempts to eradicate the disease (in several
languages)
N The US Centers for Disease Control and Prevention
provides information about polio vaccination
N The UK National Health Service Choices website has
information on polio
N MedlinePlus provides links to more resources on polio (in
English and Spanish)
N Personal stories about polio are available through the
British Polio Fellowship Heritage Project; the National
Museum of American History ‘‘Whatever happened to
polio?’’ website includes an archive of polio-related
pictures
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